Sustained Medication Reduction Following Unilateral VIM Thalamic Stimulation for Essential Tremor.

Tremor Other Hyperkinet Mov (N Y)

Department of Neurology, University of South Florida College of Medicine, Parkinson's Disease and Movement Disorders Center, Tampa, Florida, United States of America ; UF Center for Movement Disorders and Neurorestoration, Gainesville, Florida, United States of America.

Published: July 2013

Background: Deep brain stimulation (DBS) is an increasingly utilized therapeutic modality for the management of medication refractory essential tremor (ET). The aim of this study was to determine whether DBS allowed for anti-tremor medication reduction within the year after the procedure was performed.

Methods: We conducted a retrospective chart review and telephone interviews on 34 consecutive patients who had been diagnosed with ET, and who had undergone unilateral DBS surgery.

Results: Of the 34 patients in our cohort, 31 patients (91%) completely stopped all anti-tremor medications either before surgery (21 patients, 62%) or in the year following DBS surgery (10 patients, 29%). Patients who discontinued tremor medications before DBS surgery did so because their tremors either became refractory to anti-tremor medication, or they developed adverse events to tremor medications. Patients who stopped tremor medications after DBS surgery did so due to sufficient tremor control. Only three patients (9%) who were taking tremor medications at the time of surgery continued the use of a beta-blocker post-operatively for the purpose of hypertension management in all cases.

Discussion: The data from this study indicate that medication cessation is common following unilateral DBS for ET.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569968PMC
http://dx.doi.org/10.7916/D8ZG6QZ2DOI Listing

Publication Analysis

Top Keywords

tremor medications
16
dbs surgery
12
medication reduction
8
essential tremor
8
anti-tremor medication
8
patients
8
unilateral dbs
8
surgery patients
8
medications dbs
8
tremor
7

Similar Publications

Tongue tremor suggesting tick-borne encephalitis.

Pract Neurol

January 2025

Clinical Department of Medical, Surgical, and Health Sciences, University of Trieste, Trieste, Friuli-Venezia Giulia, Italy

View Article and Find Full Text PDF

Protocol for recording physiological signals from the human cerebellum using electroencephalography.

STAR Protoc

January 2025

Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA; Initiative for Columbia Ataxia and Tremor, Columbia University, New York, NY 10032, USA. Electronic address:

As Purkinje cells of the cerebellum have a very fast firing rate, techniques with high temporal resolution are required to capture cerebellar physiology. Here, we present a protocol to record physiological signals in humans using cerebellar electroencephalography (cEEG). We describe steps for electrode placement and recording.

View Article and Find Full Text PDF

Emerging Deep Brain Stimulation Targets in the Cerebellum for Tremor.

Cerebellum

January 2025

Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Deep brain stimulation (DBS) for essential tremor is remarkably effective, leading to over 80% reduction in standardized tremor ratings. However, for certain types of tremor, such as those accompanied by ataxia or dystonia, conventional DBS targets have shown poor efficacy. Various rationales for using cerebellar DBS stimulation to treat tremor have been advanced, but the varied approaches leave many questions unanswered: which anatomic target, stimulation settings, and indications seem most promising for this emerging approach.

View Article and Find Full Text PDF

Background: Ataxia-telangiectasia (Louis-Bar syndrome) is a rare genetic disorder characterized by progressive ataxia, ocular telangiectasias, immunodeficiency and increased cancer risk due to impaired DNA repair.

Phenomenology Shown: Thorough clinical and subsequently radiological examination in a 19-year-old woman with a history of previously undiagnosed, progressive gait ataxia since early childhood, diffuse large B-cell lymphoma and severe combined immunodeficiency revealed the eponymous features of the disease, ocular telangiectasias and cerebellar atrophy, enabling targeted genetic testing.

Educational Value: Ocular telangiectasias represent an important clue for a diagnosis of ataxia-telangiectasia in young patients with progressive ataxia, implicating awareness of increased malignancy risk and treatment of immunodeficiency.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!